|
Recent Developments |
|
30-DEC-11
Lyka Labs has announced that the company has recently entered into a technology transfer agreement with a Pharma company based in Republic of Turkey.
17-NOV-11
Lyka Labs has announced that the company has entered MOU with European based company for Transfer Known- How / Technology to manufacture lyophilized product for a consideration of USD 2,50,000 and Royally for
... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 30-Sep-2015(3) | 30-Jun-2015 (12) | 30-Jun-2014 (15) | | Net sales | 195.24 | 904.84 | 805.76 | | Other Income | 1.73 | 17.07 | 59.36 | | Total Income | 196.97 | 921.91 | 865.12 | | Cost of goods sold | 164.36 | 798.19 | 906.62 | | OPBDIT | 32.61 | 123.72 | -41.50 | | PAT | 31.86 | 13.67 | -72.24 | | Gross Block | - | - | - | | Equity capital | 215.80 | 215.80 | 215.80 | | EPS (Rs.) | - | 0.58 | -3.41 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 22.76 - 125.86 | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 16.6 | 13.4 | -4.8 | | Net margin (% of OI) | 16.2 | 1.5 | -8.4 |
|
|
Detailed Financials
|
|
|
|
|
